The Department of Health – Abu Dhabi (DoH) has issued a new Medical Laboratory Allied Healthcare Professionals Scope of Practice. Published in July 2026 and effective in October 2026, the document applies to DoH-licensed phlebotomists, medical laboratory technicians, medical laboratory technologists, and clinical scientists, as well as healthcare facilities operating medical laboratory services in Abu Dhabi.

For laboratory staff, this is more than a licensing document. It connects daily bench responsibilities with documented competency, quality control, method verification, critical-result reporting, proficiency testing, information security, turnaround time, and inspection readiness.

Who is covered?

The scope applies across hospitals, medical and diagnostic centers, clinics, long-term and home-care facilities, mobile health units, blood banks, biobanks, research facilities, forensic laboratories, and reference laboratories.

It defines four professional groups:

• Phlebotomist
• Medical Laboratory Technician
• Medical Laboratory Technologist
• Clinical Scientist

The document distinguishes the duties of each title. A staff member’s assigned work should therefore match the individual’s DoH license, education, verified competence, and facility-granted authorization.

What changes for day-to-day laboratory practice?

1. Competency must match every assigned task

The new scope states that laboratory professionals must maintain up-to-date competence for all tasks assigned to them, including equipment operation and troubleshooting. Advanced duties require evidence of training and experience, followed by a procedure-specific competency assessment through the appropriate facility body.

This means that a general orientation record may not be enough for specialized work. Laboratories should be able to show who is authorized and competent for activities such as:

• Body-fluid cell counts and differentials
• Bone marrow or specialized morphology work
• Coagulation factor assays and mixing studies
• Flow cytometry or molecular testing
• Specialized analyzer channels or reflex algorithms
• Method validation and verification
• Proficiency-testing management
• Technical troubleshooting and result interpretation

Practical action: Compare each staff member’s bench assignment with their license title, training records, competency assessment, and current authorization matrix. Close any gap before independent testing continues.

2. Medical laboratory technologists have defined QC and validation responsibilities

The DoH document specifically includes running or overseeing QC programs, assessing test performance against established quality criteria, and evaluating or adjusting procedures and methods. It also includes assessment and verification of new methodologies through a structured, documented process approved by laboratory management.

For an MLS, this supports active involvement in:

• Reviewing daily QC and trends
• Documenting corrective action before patient reporting
• Lot-to-lot comparison
• Calibration verification and analytical measurement range checks
• Method comparison and verification
• Establishing or verifying reference intervals where required
• Reagent, calibrator, and control traceability
• Reviewing analyzer maintenance and performance records

It does not mean that any technologist may independently approve every validation. Approval and responsibility must still follow the laboratory’s governance structure, authorized scope, SOPs, manufacturer instructions, and accreditation requirements.

3. Critical and abnormal findings must be escalated and documented

All laboratory professionals must promptly report adverse events, incidents, and critical results through the facility reporting system, with accurate identification, documentation, and compliance with established timeframes.

Technicians are expected to recognize complex, critical, or abnormal findings and escalate them to a supervising technologist or pathologist according to internal policy. Technologists may review results, make technical decisions, and troubleshoot within their competence, but must seek support when a matter falls outside their authorized scope.

Practical action: Recheck the laboratory’s critical-result list, read-back process, escalation pathway, downtime procedure, and documentation fields. Staff should know exactly whom to contact when the first recipient is unavailable.

4. LIS work requires traceability and controlled authorization

For medical laboratory technologists, the scope includes entering, verifying, and managing laboratory data in the LIS while observing data traceability, user-access control, audit-trail, and authorization requirements.

Shared passwords, inappropriate access levels, undocumented manual result changes, or verification by staff without authorization can create both patient-safety and compliance risks.

Practical action: Review user roles against current duties. Remove obsolete access, confirm that overrides and corrected reports are traceable, and retain evidence of authorization for result verification.

5. Turnaround time and downtime readiness are professional obligations

The scope requires compliance with defined turnaround times and approved downtime or contingency procedures. This makes continuity planning part of professional practice, not merely a management exercise.

Each section should know how to continue essential testing when the analyzer, LIS, transport system, power supply, or reagent inventory is disrupted. Downtime worksheets, manual result-entry controls, critical-result communication, and restoration reconciliation should be tested—not simply stored in a folder.

6. Inventory and equipment oversight are explicitly included

The general obligations include proper inventory management to prevent shortages. Technologists must also demonstrate proficiency in instrument operation, routine maintenance, calibration, performance verification, and troubleshooting.

For busy hematology and coagulation sections, useful evidence includes:

• Minimum and maximum stock levels
• Expiry and open-vial stability tracking
• Lot and shipment traceability
• Reagent shortage escalation plans
• Scheduled and unscheduled maintenance records
• Corrective-action documentation after QC failure or analyzer malfunction
• Backup analyzer or referral-laboratory arrangements

7. Inspection support is part of the role

The document requires laboratory professionals to support surveyors and inspectors during relevant CAP, JCI, ISO 15189, DoH, and occupational-health-and-safety assessments.

Staff should be able to explain what they do, show the current controlled procedure, retrieve their competency evidence, demonstrate QC review, and describe what happens when a process fails. Inspection readiness should be built into routine work rather than performed only before a scheduled visit.

Technician, technologist, and clinical scientist: an important distinction

The new scope separates responsibility according to professional title.

A medical laboratory technician performs routine testing and pre-analytical processing, operates analyzers, performs internal quality checks, recognizes problems, and escalates complex or critical findings under the applicable supervision and facility policy.

A medical laboratory technologist performs complex and specialized testing, reviews result accuracy within scope, oversees QC, contributes to documented method development and verification, manages PT according to policy, makes technical decisions within competence, and may supervise or guide other laboratory staff.

A clinical scientist has responsibility for high-complexity investigations, advanced diagnostic systems, method development and validation, scientific interpretation, consultation, quality oversight, and multidisciplinary contribution within an authorized laboratory and scientific scope.

These descriptions should not be used in isolation to redesign job roles. Facilities must align them with the DoH license, the UAE Professional Qualification Requirements, clinical privileges where applicable, organizational policy, and individual competency evidence.

A readiness checklist for October 2026

Laboratory leaders and section staff can use the following review:

Review area	Evidence to check
Role alignment	License title, job description, bench assignment, authorization matrix
Competency	Current task-specific assessments, training, retraining after gaps or changes
Specialized testing	Documented approval for advanced procedures and interpretation
QC	QC review, trend monitoring, corrective action, authorization to resume testing
Validation/verification	Approved protocol, raw data, acceptance criteria, final authorization
PT/EQA	Enrollment, handling, review, investigation, corrective action, staff involvement
Critical results	Notification time, recipient, read-back, escalation, downtime process
LIS	Individual accounts, appropriate roles, audit trails, corrected-result controls
Equipment	Maintenance, calibration, performance verification, troubleshooting competence
Inventory	Lot and shipment traceability, expiry monitoring, shortage contingencies
Continuity	Analyzer and LIS downtime procedures, backup testing, reconciliation records
Inspection readiness	Staff access to controlled SOPs and ability to explain routine processes

What should an individual MLS do now?

Start with your own assigned bench. List the tests, analyzers, manual procedures, technical decisions, and supervisory duties you perform. Then compare that list with your license title, job description, competency records, and the new DoH scope.

If something does not align, do not simply stop a necessary service without coordination. Raise the gap with your supervisor or quality team so the facility can clarify authorization, provide training, complete competency assessment, revise documentation, or reassign the duty safely.

Key takeaway

The new DoH scope makes the connection between professional title and bench responsibility more explicit. For Abu Dhabi laboratories, the highest-value preparation is a documented review of staff authorization, task-specific competence, QC and validation roles, critical-result processes, LIS access, and downtime readiness before the October 2026 effective date.

Educational disclaimer

This article is for professional education and does not replace the controlled DoH document, UAE law, facility policy, manufacturer instructions, accreditation requirements, or advice from a laboratory director, quality department, or licensing authority. Laboratories should verify the current online version and apply it through their authorized governance process.

References

1. Department of Health – Abu Dhabi. Medical Laboratory Allied Healthcare Professionals Scope of Practice. Publication date: July 2026; effective date: October 2026.
2. Department of Health – Abu Dhabi. Scope of Practice resource page. Accessed September 7, 2026.
3. Department of Health – Abu Dhabi. Unified Healthcare Professional Qualification Requirements. Referenced by the 2026 scope-of-practice document.

Hashtags: #MedicalLaboratoryScience #MLS #LaboratoryMedicine #AbuDhabiDoH #UAEHealthcare #ISO15189 #QualityControl #MedTech